GRN is associated with poor prognosis in BC (Elkabets et al., 2011; Yeh et al., 2015), and specifically in triple-negative breast cancer, a population of bone marrow cells secretes GRN to support stromal activation and robust tumor growth in young mice (Marsh et al., 2016). The gene discussed is GRN; the disease is triple-negative breast carcinoma.